Evidence map›Paper›PMID 37568724›Full record

ArticleCancers2023

Significance of Furin Expression in Thyroid Neoplastic Transformation.

Maria Teresa Azevedo, Sofia Macedo, Sule Canberk, Luís Cardoso, Tiago Bordeira Gaspar, Ana Pestana, Rui Batista, Manuel Sobrinho-Simões, Paula Soares

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Maria Teresa Azevedoi3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.
Sofia Macedoi3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0001-7752-998X
Sule Canberki3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-3736-1323
Luís Cardosoi3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.
Tiago Bordeira Gaspari3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-7410-7869
Ana PestanaCharité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Rui Batistai3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.
Manuel Sobrinho-Simõesi3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.
Paula Soaresi3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0001-9607-6998
Universidade do Porto · PTCharité - Universitätsmedizin Berlin · DE

Funding

European Regional Development Fund NORTE-01-0145-FEDER-072678Fundação para a Ciência e Tecnologia RESEARCH4COVID-19/625Fundação para a Ciência e Tecnologia SFRH/BD/137802/2018Norte Portugal Regional Operational Programme NORTE-01-0145-FEDER-000051
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACE2Furinthyroidthyroid neoplasmsTMPRSS2

Identifiers

PMID37568724
PMCPMC10417020
OpenAlexW4385454767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.